Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

  • Australia’s GDP inches higher in March 2025 quarter
    • News

    Australia’s GDP inches higher in March 2025 quarter

    Australia’s economic growth, as measured by the ABS-compiled chain volume GDP statistics that adjust for price increases, edged higher by a lower than expected 0.2 per cent in the March 2025 quarter. The accompanying ABS-prepared commentary noted that extreme weather events dampened domestic demand and reduced exports. It added that weather impacts were particularly evident

    Read More
    Public
  • Soul Patts and Brickworks Strike $14 Billion Deal to Create a Newly Capitalised ASX-Listed Company
    • News

    Soul Patts and Brickworks Strike $14 Billion Deal to Create a Newly Capitalised ASX-Listed Company

    A Transformative $14 Billion Merger In a bold move that will reshape Australia’s industrial and investment sectors, Washington H. Soul Pattinson (ASX:SOL) and Brickworks (ASX:BKW) have agreed to a transformative merger that will create a new $14 billion ASX-listed entity. The deal will dismantle their long-standing cross-shareholding and replace it with a unified, more investable

    Read More
    Public
  • TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint
    • News

    TruScreen Secures NZ$2.35M in Fresh Capital to Expand Global Cervical Screening Footprint

    TruScreen Group Limited (NZX/ASX:TRU), a medical device company focused on real-time cervical cancer screening, has raised NZ$2.35 million from a share placement that drew strong interest from  investors across Asia, including some new investors from Singapore and Hong Kong. These additional funds will be used to advance the company’s AI-powered cervical cancer detection technology amid

    Read More
    Public
  • WiseTech Expands Global Footprint with $2.1B Acquisition of e2open
    • News

    WiseTech Expands Global Footprint with $2.1B Acquisition of e2open

    WiseTech Global (ASX:WTC) has taken a decisive step toward cementing its position as a leading force in global logistics technology, announcing a binding agreement to acquire US-based e2open (NYSE:ETWO) for an enterprise value of US$2.1 billion. The acquisition is poised to transform WiseTech’s global reach and accelerate its vision of becoming the operating system for

    Read More
    Public
  • The RBA eases monetary policy, but still sees a cloudy outlook
    • News

    The RBA eases monetary policy, but still sees a cloudy outlook

    RBA benchmark rate is cut by 25 basis points at the May Board meeting As was widely expected by all and sundry, the RBA’s benchmark interest rate was reduced by 25 basis points to 3.85% at the 19-20 May RBA Board meeting. Policy makers even briefly considered whether a 50 basis point cut was an

    Read More
    Public
  • Saunders Secures $27M Contract to Boost Gold Production at Kalgoorlie
    • News

    Saunders Secures $27M Contract to Boost Gold Production at Kalgoorlie

    Expanding Western Australia’s Gold Processing Capacity The Australian resources sector has gained fresh momentum as Saunders International Limited (ASX:SND) announced a significant contract win. The $27 million agreement, awarded by Primero, marks Saunders’ continued involvement in enhancing operations at Kalgoorlie Consolidated Gold Mines (KCGM), one of Western Australia’s iconic mining sites. This contract will see

    Read More
    Public
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path

    A growing U.S. demand for faster, AI-powered tools in cardiopulmonary care is opening up substantial commercial opportunities for Australian medtech company 4DMedical (ASX:4DX). The Melbourne-based imaging innovator has secured a significant contract with Intermountain Health—one of the United States’ largest and most respected health systems—for the rollout of its newly FDA-cleared Pulmonary Hypertension Analysis (PHA™)

    Read More
    Public
  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    • News

    Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program

    Race Oncology (ASX:RAC) has taken a step towards the development of a new cancer-fighting drug therapy, dosing the first patient in its Phase 1 trial of RC220, a reformulated version of bisantrene, aimed at treating advanced solid tumours. The early-stage trial marks a key milestone for Australia’s biotech sector and positions Race Oncology at the forefront

    Read More
    Public
  • March 2025 quarter CPI above expectations – but RBA cut still likely
    • News

    March 2025 quarter CPI above expectations – but RBA cut still likely

    The March 2025 quarter CPI data released today were a touch above market expectations. The headline CPI rose by 0.9% over the quarter, well up on the slight 0.2% increase reported in the prior quarter. This delivered an annual CPI increase in the March 2025 quarter of 2.4%, which matched that reported in the prior

    Read More
    Public
  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians

    Just 12 months after launching their refurbished tech division, eCommerce company Harris Technology (ASX: HT8) is set to consolidate its position as a leading seller of refurbished tech products in Australia by expanding into new product categories.  The expansion opportunity comes after Harris Technology caught the attention of Taiwanese tech giant FSP Technology Inc which

    Read More
    Public
  • «
  • ‹
  • 7
  • 8
  • 9
  • 10
  • 11
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.